Prana Biotechnology Ltd (PRAN) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Biotech_Invest Biotech_Invest 10/01/2015 3 months $0.90 $0.76 -16.12% 16 Ended
Comments: PRAN-scam will be delisted from NASDAQ if not remove partial clinical hold before end of 2015
RoyF RoyF 04/29/2015 1 Year $1.21 $3.98 +228.93% 228 Ended
Comments: PBT2 is recommended for orphan drug designation in Europe, which should facilitate faster FDA ok
OnyedikachiErugo OnyedikachiErugo 02/17/2015 1 Year $1.09 $0.51 -53.21% -53 Ended
Comments:
playerprice playerprice 02/13/2015 1 month $1.11 $1.17 +5.41% 5 Ended
Comments:
Magi Magi 01/14/2015 1 Year $1.53 $0.57 -62.76% -62 Ended
Comments: Anticipate incredible gains in 2015.
danipre danipre 07/11/2014 1 month $2.61 $2.12 -18.77% -18 Ended
Comments:
Joward Joward 02/28/2014 1 Year $10.84 $1.11 -89.76% 89 Ended
Comments:
villanueva villanueva 02/26/2014 1 Year $11.08 $1.11 -89.98% -89 Ended
Comments:
markrefuerzo markrefuerzo 02/26/2014 1 Year $10.95 $1.11 -89.86% -89 Ended
Comments:
OzchiL OzchiL 11/22/2013 3 months $4.64 $8.76 +88.79% 88 Ended
Comments: PBT2 has the potential to increase Prana market cap to billions

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.